Paper Details

  1. Home
  2. Paper Details

Anti-arrhythmic therapy in patients with non-ischemic cardiomyopathy.

Author: AlTurkiAhmed, ProiettiRiccardo, RussoVincenzo

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Anti-arrhythmic drugs (AADs) are essential for secondary prevention of ventricular arrhythmias in patients with non-ischemic cardiomyopathy. Beta-blockers, disopyramide, sotalol, and amiodarone are commonly used drugs for this purpose, each with its own advantages and disadvantages.
Paper Details　
Original Abstract of the Article :
Implantable cardiac defibrillators (ICD) are the foundation of therapy for the prevention of sudden cardiac death. While ICDs prevent SCD, they do not prevent the occurrence of ventricular arrhythmias which are usually symptomatic. Though catheter ablation has been successful in substrate modificati...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.phrs.2019.03.004

データ提供：米国国立医学図書館（NLM）

Anti-Arrhythmic Therapy in Non-Ischemic Cardiomyopathy

The heart is a complex and vital organ, its rhythms crucial to our very existence. This study delves into the challenging landscape of anti-arrhythmic therapy for patients with non-ischemic cardiomyopathy, a condition affecting the heart muscle.

Navigating the Rhythms of the Heart

The study highlights the importance of anti-arrhythmic drugs (AADs) in preventing ventricular arrhythmias in patients with non-ischemic cardiomyopathy. The authors discuss the use of various AADs, including beta-blockers, disopyramide, sotalol, and amiodarone, emphasizing the need for individualized treatment plans based on the specific type of cardiomyopathy. It's like navigating a labyrinth of heart rhythms, carefully choosing the right path to restore harmony.

The Heart's Resilience

This research underscores the importance of personalized medicine in managing cardiac conditions. The authors emphasize the need for a tailored approach to anti-arrhythmic therapy, taking into account the unique characteristics of each patient and their specific type of cardiomyopathy. It's like understanding the unique flora and fauna of a specific desert region, adapting strategies to best navigate the challenges of the environment.

Dr.Camel's Conclusion

This study shines a light on the complex and ever-evolving landscape of anti-arrhythmic therapy. It's a reminder that managing cardiac conditions requires a thoughtful and meticulous approach, akin to carefully navigating a challenging desert terrain.

Date :
  1. Date Completed 2020-03-03
  2. Date Revised 2020-03-03
Further Info :

Pubmed ID

30844534

DOI: Digital Object Identifier

10.1016/j.phrs.2019.03.004

Related Literature

Article Analysis
・Side Effects of sotalol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.